AWS Infrastructure Fuels Classiq’s 6 Quantum Chemistry Breakthroughs

Classiq has outlined a complete quantum-classical pipeline for computational chemistry and binding energy estimation. The project, conducted as part of Hatch’s Dimension X open innovation challenge in Singapore, focused on predicting binding energy, the energy released when a molecule docks into a protein, a critical factor in drug discovery and biochemical process optimization. Calculations for this complex process were performed on Amazon Web Services infrastructure utilizing a c6i.16xlarge instance equipped with 64 vCPUs and 128 GB of memory. This approach combines high-performance parallelized Density Functional Theory with a variational quantum eigensolver, accessible through the Classiq platform, to improve accuracy beyond traditional methods. The resulting workflow leverages AWS resources for classical computation and quantum computing to account for quantum correlations, addressing limitations in strongly correlated molecular environments.

Predicting Binding Energy

Industry leaders predict a significant shift in drug discovery and materials science this year, driven by advancements in accurately calculating binding energy, the crucial metric determining the strength of molecular interactions. Early-stage computational prediction of this quantity is becoming increasingly vital, allowing research teams to prioritize promising compounds before investing in costly laboratory experiments. While conventional chemistry methods perform adequately for smaller systems, they struggle with accuracy in complex molecular environments and become computationally prohibitive as system size increases; this limitation is now being addressed through hybrid quantum-classical approaches. Classiq recently completed a project demonstrating a complete pipeline designed to overcome these challenges, leveraging the power of both classical and quantum computing. The project, undertaken as part of Dimension X, an open innovation challenge hosted by Hatch in Singapore, focused on building a workflow for estimating binding energy with improved precision.

The team explains the need for a more efficient and reliable method. This hybrid approach strategically allocates computational tasks; AWS resources handle the intensive classical calculations, while quantum computing tackles the complexities of quantum correlations, increasing accuracy beyond what DFT alone provides. The team employed a fragment-environment embedding approach to maintain tractability as system size grows, a critical factor in simulating realistic biological systems. The goal, according to Classiq, is to formulate ligand-protein interactions and binding energy estimation as a quantum chemistry problem, paving the way for more accurate and efficient molecular design. This work represents a step toward accelerating the development of new therapeutics and materials by reducing the reliance on trial-and-error experimentation and optimizing the initial stages of research.

The Problem: Why Binding Energy Prediction Is Hard

Predicting how strongly molecules bind, a process central to biochemistry and drug discovery, remains a significant computational hurdle, even as researchers refine methods for simulating these interactions. Molecular recognition, where a ligand binds to a protein and alters its function, underpins countless biological processes, from enzyme activity to therapeutic effects; accurately quantifying this binding affinity is therefore paramount. Determining binding energy computationally necessitates calculating ΔE = E(complex) − E(pocket) − E(ligand), a deceptively simple equation that masks substantial complexity when applied to realistic biological systems containing over 100 atoms and hundreds of interacting electrons. Classical computational methods struggle to balance accuracy and efficiency. Molecular mechanics approaches, like Molecular Mechanics Generalized Born Surface Area, offer speed but rely on parameterized force fields, indirectly capturing quantum effects through approximations.

Density Functional Theory provides a better compromise, scaling polynomially with system size, but exhibits known limitations when modeling noncovalent interactions, charge transfer, and complex electronic structures. More accurate wavefunction methods, such as Full Configuration Interaction, scale exponentially, rendering them impractical for all but the smallest molecules. This approach addresses both challenges, combining high-performance parallelized DFT calculations with a variational quantum eigensolver, made accessible through the Classiq platform. The result is a workflow that uses resources to handle the heavy classical computation and quantum computing to account for quantum correlations in the calculations, increasing accuracy beyond what DFT alone provides.

Researchers are now exploring how to partition the problem, treating a small, crucial region of the molecule quantum mechanically while handling the surrounding environment with DFT. The team explains the need to focus quantum calculations on the most critical parts of the system given current hardware limitations. Classiq’s platform aims to streamline this process, allowing researchers to specify the quantum chemistry problem and automatically generate optimized quantum circuits, a crucial step toward scaling these calculations for larger, more complex systems.

The Pipeline: From Crystal Structure to Binding Energy

This approach tackles a longstanding challenge: balancing the accuracy of quantum mechanical calculations with the computational resources required for large molecular systems. The core of the pipeline lies in a projection-based Wavefunction-in-DFT embedding technique. This method partitions a large molecular system into a chemically active fragment and a surrounding environment. This division allows for a reduction in the computational burden without sacrificing accuracy, as the environment’s electronic influence is incorporated into the fragment’s Hamiltonian. The initial stage begins with crystallographic structures sourced from the Protein Data Bank, which are then processed and prepared for DFT calculations. Crucially, the pipeline isn’t simply about running quantum algorithms; it’s about intelligent problem reduction. A system of up to approximately 100 atoms can be reduced to an active space, with the environment’s influence consistently accounted for. Classiq’s platform plays a key role in this process, synthesizing optimized quantum circuits from high-level functional models.

Instead of manual gate-level engineering, the problem is defined at the chemistry level, specifying the Hamiltonian, electron counts, and desired ansatz type. Validation on benchmark systems has shown promising results. These early successes suggest a future where accurate binding energy predictions are routinely achievable, accelerating drug discovery and materials science.

Technical Implementation: HPC on AWS

Standard Density Functional Theory calculations, a cornerstone of modern chemical research, present a formidable scaling challenge; the computational cost increases proportionally to the fourth power of the number of basis functions, denoted as O(N⁴). Because the number of these basis functions scales linearly with the number of atoms within a molecule, simulating large biomolecules like enzymes quickly becomes intractable using conventional methods. This computational bottleneck is prompting a move toward high-performance computing infrastructure to tackle these challenges, with cloud-based solutions gaining prominence. This specific configuration demonstrates the level of compute resources now required for advanced chemistry work, and signals a trend toward utilizing specialized cloud infrastructure for complex simulations. Experts anticipate that future advancements will focus on partitioning these calculations into manageable components, allowing for parallel processing across multiple nodes. That increase in computational demand is not linear; doubling the atom count in a simulation multiplies the computation of electron repulsion integrals by a factor of approximately 16. This exponential growth underscores the need for algorithmic innovation alongside hardware upgrades.

Scaling Across Many Ligands

Industry leaders predict a significant bottleneck will emerge as computational chemistry increasingly relies on hybrid quantum-classical approaches; specifically, the need to recalculate complex systems for each new molecular variation. While quantum computing promises to revolutionize drug discovery and materials science, the practicalities of applying it to large-scale screening campaigns are becoming clearer, and reveal a surprising limitation. Every new ligand configuration tested against the same pocket requires re-running the complex calculation, a demand that quickly escalates computational costs. This isn’t a fundamental limitation of quantum mechanics, but rather a consequence of current methodologies. As the pipeline matures, the sheer number of these calculations presents a challenge. To address this, researchers are leveraging cloud infrastructure to parallelize the workflow. The architecture utilizes AWS Batch, a managed service that automatically schedules jobs and scales execution across Amazon EC2 instances.

Each ligand configuration becomes an independent job, allowing for linear cost scaling with the number of configurations tested. This modularity is designed to scale further as quantum hardware capacity expands, distributing tasks across multiple quantum processing units. The ultimate goal, according to the project’s design, is to ensure the pipeline remains a robust and scalable solution for large-scale biochemical screening as more powerful quantum resources become available.

Conclusion

This year will see a significant expansion in the feasibility of hybrid quantum-classical pipelines for complex chemical calculations, specifically in the realm of ligand-protein binding. Importantly, the pipeline combines high-performance parallelized Density Functional Theory calculations with a variational quantum eigensolver, made accessible through the Classiq platform. This methodology strategically allocates computational resources, focusing the quantum treatment on the chemically active fragment of the molecule while the larger protein environment is handled classically. This division saves valuable time and resources, allowing for meaningful binding estimates without discarding crucial structural context. Classiq anticipates a future where quantum computing seamlessly integrates with existing high-performance computing resources to tackle increasingly complex biochemical problems.